The optimization of glucocorticoid therapy for long term treatment in Connective Tissue Diseases
42:58
Explaining Systemic Sclerosis (SSc) to family and friends
33:52
How to explain the antiphospholipid profile to my patients?
1:16:54
Strengthening the intergenerational contract: investing for intergenerational fairness
11:40
Connective Tissue Disease: The Intersection Between Rheumatology and Dermatology
51:03
Critical Adrenal Insufficiency
48:01
2023 ACR/EULAR AntiPhospholipid Syndrome (APS) classification criteria
58:54
Optimizing Oxidation in the Care of Chronically Ill Patients
17:26